Oporto, Zeironn M.
HRN: 26-27-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
11/26/2024
11/26/2024
OU
0.5mg
Once
NB Care
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes